No takes yet. Share an insight, caveat, or question.
Uncovers the impact of KRAS signaling intensity on tumor progression in pancreatic cancer, suggesting implications for targeted therapies.
Salehi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: